Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 599, pseudogene (RNU6-599P)** is a human pseudogene that is related to the U6 small nuclear RNA (snRNA) family, which is best known for its critical role in the splicing machinery of eukaryotic pre-mRNA[2][3]. Unlike its functional counterparts, RNU6-599P does not produce an active small nuclear RNA and is classified as a non-coding RNA pseudogene[2]. As with many U6 snRNA-derived pseudogenes, it is generally not transcribed into a functional product, although growing evidence suggests that some pseudogenes may influence gene regulation through non-coding mechanisms[4]. There is no evidence that RNU6-599P is a direct therapeutic target, interacts with drugs, or is used as a biomarker in clinical practice[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 599, pseudogene (RNU6-599P).